These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9226005)

  • 1. Inhibition of replication of HIV in primary monocyte/macrophages by different antiviral drugs and comparative efficacy in lymphocytes.
    Aquaro S; Perno CF; Balestra E; Balzarini J; Cenci A; Francesconi M; Panti S; Serra F; Villani N; Caliò R
    J Leukoc Biol; 1997 Jul; 62(1):138-43. PubMed ID: 9226005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral profile of HIV inhibitors in macrophages: implications for therapy.
    Perno CF; Balestra E; Francesconi M; Abdelahad D; Caliò R; Balzarini J; Aquaro S
    Curr Top Med Chem; 2004; 4(9):1009-15. PubMed ID: 15134554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir.
    Aquaro S; Caliò R; Balzarini J; Bellocchi MC; Garaci E; Perno CF
    Antiviral Res; 2002 Aug; 55(2):209-25. PubMed ID: 12103427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between intracellular pharmacological activation of nucleoside analogues and HIV suppression in vitro.
    Hoggard PG; Sales SD; Kewn S; Sunderland D; Khoo SH; Hart CA; Back DJ
    Antivir Chem Chemother; 2000 Nov; 11(6):353-8. PubMed ID: 11227992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of inhibitors of late stages of the replication of HIV in chronically infected macrophages.
    Perno CF; Aquaro S; Rosenwirth B; Balestra E; Peichl P; Billich A; Villani N; Caliò R
    J Leukoc Biol; 1994 Sep; 56(3):381-6. PubMed ID: 8083612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus type 1: resistance to nucleoside analogues and replicative capacity in primary human macrophages.
    Perez-Bercoff D; Wurtzer S; Compain S; Benech H; Clavel F
    J Virol; 2007 May; 81(9):4540-50. PubMed ID: 17287264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic strategies towards HIV-1 infection in macrophages.
    Perno CF; Svicher V; Schols D; Pollicita M; Balzarini J; Aquaro S
    Antiviral Res; 2006 Sep; 71(2-3):293-300. PubMed ID: 16806514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-drug combinations of emivirine and nucleoside reverse transcriptase inhibitors in vitro: long-term culture of HIV-1-infected cells and breakthrough viruses.
    Nitanda T; Wang X; Somekawa K; Yuasa S; Baba M
    Antivir Chem Chemother; 2001 May; 12(3):161-7. PubMed ID: 12959324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of reverse transcriptase inhibitors in monocyte-derived dendritic cells: a possible in vitro model for postexposure prophylaxis of sexual HIV transmission.
    Van Herrewege Y; Penne L; Vereecken C; Fransen K; van der Groen G; Kestens L; Balzarini J; Vanham G
    AIDS Res Hum Retroviruses; 2002 Oct; 18(15):1091-102. PubMed ID: 12396448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus.
    Perno CF; Newcomb FM; Davis DA; Aquaro S; Humphrey RW; Caliò R; Yarchoan R
    J Infect Dis; 1998 Aug; 178(2):413-22. PubMed ID: 9697721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT).
    Periclou AP; Nandy P; Avramis VI
    In Vivo; 2000; 14(3):377-88. PubMed ID: 10904870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxandrolone, used for treatment of wasting disease in HIV-1-infected patients, does not diminish the antiviral activity of deoxynucleoside analogues in lymphocyte and macrophage cell cultures.
    Segal DM; Perez M; Shapshak P
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Mar; 20(3):215-9. PubMed ID: 10077168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different pattern of activity of inhibitors of the human immunodeficiency virus in lymphocytes and monocyte/macrophages.
    Perno CF; Yarchoan R; Balzarini J; Bergamini A; Milanese G; Pauwels R; De Clercq E; Rocchi G; Calio R
    Antiviral Res; 1992 Apr; 17(4):289-304. PubMed ID: 1322645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected macrophages: new therapeutic strategies.
    Aquaro S; Svicher V; Schols D; Pollicita M; Antinori A; Balzarini J; Perno CF
    J Leukoc Biol; 2006 Nov; 80(5):1103-10. PubMed ID: 16931601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of acyclic nucleoside phosphonate analogues against human immunodeficiency virus in monocyte/macrophages and peripheral blood lymphocytes.
    Balzarini J; Perno CF; Schols D; De Clercq E
    Biochem Biophys Res Commun; 1991 Jul; 178(1):329-35. PubMed ID: 2069572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic inhibition of HIV-1 in activated and resting peripheral blood mononuclear cells, monocyte-derived macrophages, and selected drug-resistant isolates with nucleoside analogues combined with a natural product, resveratrol.
    Heredia A; Davis C; Redfield R
    J Acquir Immune Defic Syndr; 2000 Nov; 25(3):246-55. PubMed ID: 11115955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of Human Endogenous Retrovirus Type K to Reverse Transcriptase Inhibitors.
    Contreras-Galindo R; Dube D; Fujinaga K; Kaplan MH; Markovitz DM
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides.
    Perno CF; Yarchoan R; Cooney DA; Hartman NR; Gartner S; Popovic M; Hao Z; Gerrard TL; Wilson YA; Johns DG
    J Exp Med; 1988 Sep; 168(3):1111-25. PubMed ID: 2844951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of reverse transcriptase and protease inhibitors in two-drug combinations against human immunodeficiency virus replication.
    Deminie CA; Bechtold CM; Stock D; Alam M; Djang F; Balch AH; Chou TC; Prichard M; Colonno RJ; Lin PF
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1346-51. PubMed ID: 8725999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of HIV dynamics and drug resistance in macrophages.
    Aquaro S; Caliò R; Balestra E; Bagnarelli P; Cenci A; Bertoli A; Tavazzi B; Di Pierro D; Francesconi M; Abdelahad D; Perno CF
    J Biol Regul Homeost Agents; 1998; 12(1-2 Suppl):23-7. PubMed ID: 9689575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.